Breast cancer treatment typically takes anywhere from several months to a year or more for early-stage disease, depending on which combination of therapies you need. Some people finish in under six months with surgery and a short course of radiation, while others spend 12 to 18 months moving through surgery, chemotherapy, radiation, and targeted therapy. Hormone-blocking medication, if prescribed, extends the commitment to 5 or even 10 years. The timeline looks different for every person because it depends on the cancer’s stage, subtype, and biology.
From Diagnosis to First Treatment
Most women begin treatment within a few weeks of diagnosis, though there’s usually a period of additional imaging, biopsies, and planning before anything starts. The Commission on Cancer recommends that most women undergo surgery within 60 days of diagnosis. Research from the University of Oklahoma found that waiting more than 42 days for surgery raised the risk of death for certain subtypes, with risk climbing 21% by 60 days and 79% by 90 days. If chemotherapy is given before surgery (called neoadjuvant treatment), that typically starts sooner, and surgery follows months later.
Surgery and Recovery
Surgery is the starting point for most early-stage breast cancers. A lumpectomy (removing the tumor and a margin of tissue) has a shorter recovery than a mastectomy, but even full mastectomy recovery takes about 3 to 4 weeks. Most people return to normal daily activities within that window, though strenuous exercise and heavy lifting take longer.
If you’re having breast reconstruction at the same time as your mastectomy, the surgical recovery period is similar but may involve tissue expanders that are gradually filled over several weeks. When reconstruction is delayed until after radiation, the final procedure is typically deferred 6 to 12 months after radiation ends.
Chemotherapy: 3 to 6 Months
Not everyone with breast cancer needs chemotherapy, but when it’s part of the plan, it usually runs 3 to 6 months for early-stage disease. Treatments are given in cycles, typically once every one to three weeks, with rest periods in between to let your body recover. A common pattern is four to eight cycles spread across that timeframe.
For advanced or metastatic breast cancer, chemotherapy may continue beyond six months and is adjusted based on how the cancer responds. In practice, your oncologist monitors your progress with scans and blood work and shifts the approach if a regimen stops working.
Radiation: 1 to 5 Weeks
Radiation therapy has gotten significantly shorter over the past decade. The traditional course ran five or more weeks of daily sessions, five days a week. A three-week schedule of 15 sessions became a widely adopted standard and is now common internationally. More recently, a one-week course of just five treatments has proven equally effective for many patients. A large clinical trial published in The Lancet (the FAST-Forward trial) confirmed that this condensed one-week schedule controls cancer just as well as the three-week version, with similar side effects.
Which schedule you’re offered depends on your cancer’s characteristics and your treatment center. Radiation typically begins a few weeks after surgery, or after chemotherapy finishes if chemo was part of the plan.
Targeted Therapy for HER2-Positive Cancer
About 20% of breast cancers are HER2-positive, meaning they overproduce a protein that fuels growth. These cancers are treated with drugs that specifically block that protein, given alongside or after chemotherapy. The standard course lasts one year, with infusions every three weeks. Some patients receive a combination of two targeted drugs together for up to a year, while others take a daily pill for an additional year after the infusion-based therapy ends.
This yearlong commitment is one of the reasons HER2-positive breast cancer treatment tends to have a longer overall timeline than other subtypes.
Immunotherapy for Triple-Negative Cancer
Triple-negative breast cancer, which lacks the receptors that other treatments target, may be treated with immunotherapy. The FDA-approved regimen combines immunotherapy with chemotherapy before surgery for about 24 weeks (roughly six months), followed by immunotherapy alone after surgery for up to 27 additional weeks. That’s close to a full year of immunotherapy in total, layered on top of the surgical timeline.
Hormone Therapy: 5 to 10 Years
This is the longest piece of the treatment timeline. Around 70% of breast cancers are hormone receptor-positive, meaning estrogen or progesterone drives their growth. After surgery, chemotherapy, and radiation are complete, these patients take a daily pill that blocks hormones from reaching any remaining cancer cells.
The standard course is 5 years, but research from the National Cancer Institute shows that 10 years of treatment leads to a greater reduction in cancer recurrence and death than 5 years alone. This is especially true for premenopausal women. Postmenopausal women are often prescribed 5 years of an aromatase inhibitor, sometimes preceded by a few years of a different hormone blocker. Your oncologist will weigh the benefit of extended treatment against the side effects, which can include joint pain, hot flashes, and bone thinning.
Hormone therapy doesn’t feel like “active treatment” in the way chemotherapy does. You take a pill at home and see your oncologist periodically. But it’s a real commitment that shapes daily life for years.
What a Full Timeline Looks Like
To put it all together, here’s what the active treatment phase looks like for common scenarios:
- Early-stage, hormone receptor-negative: Surgery plus 1 to 5 weeks of radiation. Active treatment wraps up in about 2 to 3 months, not counting the diagnostic workup.
- Early-stage, hormone receptor-positive: Surgery, possibly chemotherapy (3 to 6 months), radiation (1 to 5 weeks), then 5 to 10 years of daily hormone-blocking pills. Active treatment takes roughly 4 to 9 months before transitioning to the long-term medication phase.
- HER2-positive: Surgery, chemotherapy (3 to 6 months), radiation (1 to 5 weeks), and a year of targeted therapy. The intensive phase runs about 12 to 18 months.
- Triple-negative with immunotherapy: About 6 months of chemotherapy plus immunotherapy before surgery, then surgery, radiation, and up to 27 more weeks of immunotherapy. Total active treatment spans roughly 12 to 15 months.
- Metastatic (Stage IV): Treatment is ongoing and focused on controlling the cancer rather than curing it. There is no set endpoint. Regimens are adjusted over time based on how the cancer responds and what side effects are manageable.
Gaps Between Treatment Phases
The phases listed above don’t always run back-to-back seamlessly. There are built-in waiting periods: a few weeks to heal from surgery before starting chemotherapy or radiation, time between chemo cycles for your blood counts to recover, and sometimes a pause between radiation and reconstruction. These gaps add weeks or months to the overall calendar. A treatment plan that looks like “6 months” on paper often stretches closer to 8 or 9 months in real life once you account for scheduling, delays, and recovery windows.